NexImmune Inc (NEXI)
3.60
+0.14
(+4.05%)
USD |
NASDAQ |
May 10, 16:00
3.49
-0.11
(-3.06%)
After-Hours: 20:00
NexImmune Total Liabilities (Quarterly): 5.084M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.084M |
| September 30, 2023 | 6.308M |
| June 30, 2023 | 6.472M |
| March 31, 2023 | 7.086M |
| December 31, 2022 | 10.76M |
| September 30, 2022 | 9.959M |
| June 30, 2022 | 9.813M |
| March 31, 2022 | 7.921M |
| Date | Value |
|---|---|
| December 31, 2021 | 7.271M |
| September 30, 2021 | 7.432M |
| June 30, 2021 | 5.483M |
| March 31, 2021 | 6.105M |
| December 31, 2020 | 27.06M |
| September 30, 2020 | 15.93M |
| December 31, 2019 | 3.107M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.107M
Minimum
Dec 2019
27.06M
Maximum
Dec 2020
9.052M
Average
7.271M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Mind Medicine Inc | 79.47M |
| Candel Therapeutics Inc | 28.46M |
| Ventyx Biosciences Inc | 33.77M |
| NKGen Biotech Inc | 75.17M |
| CERo Therapeutics Holdings Inc | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.594M |
| Shareholders Equity (Quarterly) | 3.510M |